Comments*

 
  • Life Sciences & Biomedical Research

  • Events 

    Thursday, January 29, 2015 | 6:30 PM - 8:00 PM

    Non-Traditional Postdocs

    Speakers: Susan D. Croll (Associate Director, Pain, Addiction & Neurology Postdoctoral Program Director Regeneron Pharmaceuticals), Uzi de Haan (Director of Entrepreneur Postdoc Program at Cornell Tech), Karen Hanson Widbin (Manager of Postdoctoral Program Operations)

    Join the Science Alliance (NYAS) as we discuss the non-traditional postdoc's alternatives. Topics will include differences between academia and industry, hiring and transition mechanisms, salaries and challenges.

    Monday, February 2, 2015 | 1:30 PM - 4:30 PM

    Genome Integrity Discussion Group Meeting

    Speakers: Prasad Jallepalli (Memorial Sloan-Kettering Cancer Center), Shelley Berger (University of Pennsylvania), Iestyn Whitehouse (Memorial Sloan-Kettering Cancer Center), John Petrini (Memorial Sloan-Kettering Cancer Center)

    The Genome Integrity Discussion Group provides a forum for interactions between basic and clinical research groups working on chromosome biology and function, and at the interface between chromosome integrity and onset and progression of malignancy.

    Tuesday, February 24, 2015 | 8:30 AM - 4:30 PM

    Harnessing the Potential of Genome Editing for Drug Discovery: Translational Frontiers of in vitro and in vivo Applications

    Speakers: Chad Cowen (Massachusetts General Hospital), James Inglese (National Center for Advancing Translational Sciences, NIH), J. Keith Joung (Massachusetts General Hospital), Randall Platt (Massachusetts Institute of Technology), Yi Yang (Novartis Institutes for Biomedical Research), Lei (Stanley) Qi (University of California San Francisco)

    The emergence of genome editing technologies such as TALEN and CRISPR/Cas9 are revolutionizing our ability to rapidly engineer mammalian systems. This symposium explores the frontiers of genome editing and potential to aid therapeutic development.

    Tuesday, March 24, 2015 | 11:45 AM - 4:00 PM

    Optimization of Positive Allosteric Modulators for Difficult Targets

    Speakers: P. Jeffrey Conn (Vanderbilt University), Ron Dror (Stanford University), Christopher Fotsch (Amgen), Corey Hopkins (Vanderbilt University), Whitney Nolte (Pfizer)

    In this symposium, academic and industry scientists will describe the identification, characterization, and development of PAMs for challenging GPCRs.

    March 26 - 27, 2015

    The Role of Nutrition in Dementia Prevention and Management

    Keynote Speakers: Miia Kivipelto (Karolinska Institutet), Irwin Rosenberg (Tufts University), David Smith (University of Oxford)
    Speakers: Cédric Annweiler (Angers University Hospital), Stephen Cunnane (Université de Sherbrooke), Agnes Flöel (Charité - University Medicine Berlin), Gary Gibson (Burke Rehabilitation Center), Richard Isaacson (Weill Cornell Medical College), Heather Keller (University of Waterloo), Emeran A. Mayer (UCLA), Joshua W. Miller (Rutgers, The State University of New Jersey), Martha Clare Morris (Rush University), Suzana Petanceska (National Institute on Aging), Helga Refsum (University of Oslo), Katherine Tucker (University of Massachusetts, Lowell)

    This conference will discuss issues of epidemiological perspectives and the role of nutrition in dementia prevention and management.

  • Past Events

    Tuesday, January 27, 2015 | 8:30 AM - 4:30 PM

    Cytokine-Based Immunotherapies

    Keynote Speaker: James W. Mier (Beth Israel Deaconess Medical Center/ Harvard Medical School, Boston, MA)
    Speakers: Stephen D. Gillies (Provenance Biopharmaceuticals, Carlisle, MA), Dario Neri (Philogen, Zurich, Switzerland), Jerome Ritz (Harvard Medical School), Gilles Uzé (Université Montpellier II, Montpellier, France), K. Dane Wittrup (Massachusetts Institute of Technology, Cambridge, MA)

    Systemic toxicity currently prevents exploiting the potential of many cytokines to treat cancer, viral infections, inflammatory and autoimmune conditions. Targeted delivery of immune-stimulatory or immune-regulatory cytokines offers much promise.

    Wednesday, January 21, 2015 | 8:30 AM - 4:00 PM

    The New York Structural Biology Discussion Group 10th Winter Meeting

    Speakers: Jasna Brujic (New York University), Bridget Carragher, John Chodera, Oliver Clarke, Erik Debler, Nancy Greenbaum, David Hall, Barry Honig, Jinrang Kim (Columbia University), Nina Liu (Albert Einstein College of Medicine), Patrick Loria (Yale University), Sean McSweeney (Brookhaven National Lab), Clint Potter

    The New York Area Structural Biology Discussion Group convenes twice annually and presents talks and poster sessions from graduate students, postdocs, and laboratory heads.

    Tuesday, December 9, 2014 | 8:00 AM - 5:00 PM

    Diabetic Kidney Disease: Drug Discovery and Clinical Development Challenges

    Speakers: Matthew D. Breyer (Eli Lilly and Company), Frank C. Brosius (University of Michigan Medical School), Benjamin D. Humphreys (Brigham and Women's Hospital), Matthias Meier (F. Hoffmann-La Roche Ltd), Shahnaz Shahinfar (S. Shahinfar Consulting, Inc. and The Children's Hospital of Philadelphia), Katalin Susztak (University of Pennsylvania), Aliza Thompson (Food and Drug Administration)

    Identifying and prosecuting drug targets is challenging due to a poor understanding of pathogenesis and few biomarkers. This symposium identifies targets for preventive or therapeutic interventions and discusses challenges in clinical development.

    Monday, December 1, 2014 | 1:30 PM - 4:30 PM

    Genome Integrity Discussion Group Meeting

    Speakers: Sevinc Ercan (NYU), Laura Landweber (Princeton University), Susan Smith (NYU Langone Medical Center), Renjing Wang (Memorial Sloan Kettering Cancer Center), David J. Wynne (Laboratory of Chromosome and Cell Biology, The Rockefeller University), Xiaolan Zhao (Memorial Sloan-Kettering Cancer Center)

    The Genome Integrity Discussion Group provides a forum for interactions between basic and clinical research groups working on chromosome biology and function, and at the interface between chromosome integrity and onset and progression of malignancy.

  • Publications 

    Annals

    MARROW

    Edited by Mone Zaidi (Mount Sinai School of Medicine, New York, New York)

    A new series in Annals, MARROW presents cutting-edge manuscripts on basic, translational, and clinical bone and bone marrow biology and medicine.

    Annals

    Annals Reports

    Edited by Annals of the New York Academy of Sciences editorial staff

    This Annals volume presents two meeting reports: (1) Influencing circadian and sleep–wake regulation for prevention and intervention in mood and anxiety disorders: what makes a good homeostat?; and (2) One Medicine One Science: a framework for exploring challenges at the intersection of animals, humans, and the environment.

    Volume 1334

    Annals

    Annals Reports

    Edited by Annals of the New York Academy of Sciences editorial staff

    This Annals volume presents three meeting reports: (1) Head and neck cancer: from research to therapy and cure; (2) Sequencing the head and neck cancer genome: implications for therapy; and (3) New functions and signaling mechanisms for the class of adhesion G protein–coupled receptors.

    Volume 1333

    Annals

    A Global Research Agenda for Nutrition Science

    Edited by Annals of the New York Academy of Sciences editorial staff

    This Annals volume presents a global research agenda for nutrition science developed by the Sackler Institute for Nutrition Science in collaboration with the World Health Organization (WHO) and scientists from several academic and nonprofit institutions across the world.

    Volume 1332

    Free online access provide by the Sackler Institute for Nutrition Science

  • Podcasts

    Podcast
    April 14, 2011

    The Diabetes-Gum Disease Connection

    Good oral hygiene helps prevent tooth decay and gum disease, but the health of your mouth may have a big impact on the rest of your body too—especially if you have diabetes.

    Download (11 MB, 13:03)
    Podcast
    September 10, 2010

    What Makes Us Wise?

    Can we all be wise old owls? Science journalist Stephen Hall and neuroscientist Andre Fenton dissect what we call wisdom, from the neurons in our brain, to the social constructs behind it.

    Download (22 MB, 00:42:32)
    Podcast
    August 27, 2010

    Better Brains

    Neuroscientist Richard Restak thinks with the right mental exercises, our brains can be much better. Today he teams with writer Susan Orlean to talk about our brainy potential.

    Download (35 MB, 00:54:21)
    Podcast
    August 13, 2010

    How Prosperity Evolves

    With our economy a shambles and our environment threatened, is there any reason to be optimistic about the future? Matt Ridley says there's scientific proof to say we should be.

    Download (33 MB, 00:51:28)
  • Webinar Archives

    Webinar Archive
    March 2, 2010

    Emerging Infectious Diseases in Response to Climate Change

    Climate and weather are important components of complex ecosystems, and with these changes, the dynamic balance between the living components of ecosystems is often disturbed. Experts in climate change, climate policy, emerging infectious diseases and public health discussed the relevant and pressing issues that we as a global community face as the planet's climate is altered.

    Webinar Archive
    February 23, 2010

    Metabotropic Glutamate Receptors: Translation from Discovery to Clinical Trials

    Researchers met to discuss advances in basic and translational research on metabotropic glutamate receptors, which are promising targets in drug discovery for CNS diseases and other illnesses.

    Webinar Archive
    October 27, 2009

    Is Alzheimer's Disease Type 3 Diabetes?

    What is the connection between dysregulated neuronal insulin signaling and Alzheimer's disease? In a recent Academy webinar, some researchers argued that the neurodegenerative disease should be considered a type of diabetes.

    Webinar Archive
    April 28, 2009

    Protein Kinases: Structure-Guided Drug Discovery

    Protein kinases play a key role in almost every major pathway in eukaryotic cells. Structural approaches, including a new method called fragment-based drug design, are identifying potential targets against diseases including cancer.

  • Translational Medicine Initiative

    Macy FoundationThe Translational Medicine Initiative represents a three-year partnership between the New York Academy of Sciences and the Josiah Macy, Jr. Foundation to support the translation of basic science research into clinical applications.

    Learn more at www.nyas.org/TransMed.